Sostoyanie verkhnikh otdelov pishchevaritel'nogo trakta i ratsional'nyy vybor antisekretornoy terapii u patsientov starcheskogo vozrasta
- Authors: Burkov S.G1, Kasimtseva E.V1, Agafonova L.Y.1, Yurenev G.L1, Samsonov A.A1
-
Affiliations:
- Issue: No 2 (2015)
- Pages: 56-61
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287679
- ID: 287679
Cite item
Open Access
Access granted
Abstract
Complaints, medical history, data for physical examination and endoscopy of the upper gastrointestinal tract in 356 elderly patients were analyzed. The analysis has revealed the prevalence of erosive and ulcerative lesions of the upper gastrointestinal tract as general pathology, an imbalance between the severity of clinical manifestations and endoscopic changes, and the use of large amounts of drugs due to the presence of concomitant pathology of internal organs, especially coronary artery disease and arterial hypertension. The main group of drugs used to treat acid-related diseases is the proton pump inhibitors (PPIs). As in the older age groups, long-term regular PPI therapy is usually required, it is desirable to use the drug with the least amount of drug-drug interactions. Pantoprazole meets this requirement and surpass other PPIs on in this property.
Full Text
About the authors
S. G Burkov
Email: bourk@mail.ru
E. V Kasimtseva
Email: ekasimtseva@mail.ru
L. Yu Agafonova
Email: agafonova_lu@yandex.ru
G. L Yurenev
Email: yurenev@list.ru
A. A Samsonov
Email: aleksey.samsonov@gmail.com
References
- Бурков С.Г., Арутюнов А.Г. Гастроэзофагеальная рефлюксная болезнь у пациентов пожилого и старческого возраста. Клинические перспективы гастроэнтерол., гепатол. 200;1:31-38.
- Кишкун А.А. Биологический возраст и старение. Руководство для врачей. М., 2008. C. 13.
- Бурков С.Г. Современный подход к лечению гастроэзофагеальной рефлюксной болезни в условиях полиморбидности. Экспериментальная и клиническая гастроэнтерология. 2012;9:94-97.
- Гастроэзофагеальная рефлюксная болезнь / Под ред. Л.Б. Лазебника. М., 2012. C. 270-82.
- Положенкова Л.А. Грыжи пищеводного отверстия диафрагмы в терапевтической практике (клиника, диагностика, лечение). Дисс. канд. мед. наук. М., 1973. 19 с.
- Cameron A.J. Barretts esophagus: Prevalence and size of hiatal hernia. Am. J. Gastroenterol. 1999;94:2054-59.
- Pilotto A., Franceschi M., Leonardo G., et al. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J. Am. Geriatr. Soc. 2006;54:1537-542.
- Pob C.H., Navarro-Rodriguez T., Fass R., Review: Treatment of Gastroesophageal Reflux Disease in the Elderly. Am. J. Med. 2010; 123:496-501.
- Francesbi M., Di Mario F., Leonardo G. et al. Acid-related disorders in the eldery. Best Pract. Res. Clin. Gastroenterol. 2009;23(6): 839-48.
- Fromm Al. Care of older adult populations diagnosed with Helicobacter pylori: a rew iew of current literature. Gastroenterol. Nurs. 2009;32(6):393-98.
- Salles N. Is stomach spontaneously ageing? Pathophysiology of the stomach. Best Pract. Res. Clin. Gastroenterol. 2009;23(6):805-19.
- Moore A.R., Clinch D. Underlying mechanisms of impaired visceral pain perception in older people. J. Am. Geriatr. Soc. 2004;52(1):132-36.
- Осипенко М.Ф., Бикбулатова Е.А. Кислотозависимые заболевания и возраст. Consilium medicum. 2011;8:3-6 (репринт).
- Lindblad C.I., Hanlon J.T., Gross C.R., et al. Clinically important drug-disease interactions and their prevalence in older adults. Clin. Ther. 2006;28(8):1133-143.
- Ивашкин В.Т., Трухманов А.С. Современный подход к терапии гастроэзофагеальной рефлюксной болезни. Рос. мед. журн.
- Исаков В.А. Безопасность ингибиторов протонного насоса при длительном применении. Клин. фармакол. тер. 2004;1:26-32.
- Логинов А.Ф. Возможности использования пантопразола в терапии гастроэзофагеальной рефлюксной болезни. Фарматека. 2009;13:29-33.
- Яковенко Э.П., Яковенко А.В., Агафонова Н.А. и др. Пептические язвы, патогенетические подходы к терапии. Фарматека. 2008; 13:62-67.
- Beil W., Sewing K. F., Krommer W. Basic aspects of selectivity of pantoprazole and its pharmacological actions. Drugs Today. 1999;35(10):753-64.
- Brunner G., Athmann C., Schneider A. Longterm, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acidpeptic disease. Aliment. Pharmacol. Ther. 2012;36(1):37-47.
- Steinijans V.W., Huber R., Hartmann M., et al. Lack of pantoprazole drug interactions in man: an updated review. Int. J. Clin. Pharmocol. Ther. 1996;3(Suppl.1):31-50.
Supplementary files
